
Opus Genetics (IRD) P/E Ratio
P/E Ratio as of Oct 13, 2025: -1.14
Average-0.9938
Median-1.02
Minimum-1.17
Maximum-0.7800
-1.14
Past Month-0.36 (46.15%)
The P/E ratio for Opus Genetics (IRD) is -1.14 as of Oct 13, 2025. This represents a increase of 44.30% compared to its 12-month average P/E ratio of -0.79. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Opus Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Opus Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Opus Genetics to industry peers.
Opus Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Opus Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Opus Genetics to industry peers.
Opus Genetics (IRD) P/E Ratio Insights
See Opus Genetics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Opus Genetics (IRD)
Order type
Buy in
Order amount
Est. shares
0 shares
Opus Genetics (IRD) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Oct 1, 2025 | $1.80 | -1.02 |
Sep 2, 2025 | $1.23 | -0.70 |
Aug 1, 2025 | $1.07 | -0.55 |
Jul 1, 2025 | $0.9399 | -0.48 |
Jun 2, 2025 | $1.09 | -0.56 |
May 1, 2025 | $0.938 | -0.47 |
Apr 1, 2025 | $0.91 | -0.46 |
Mar 3, 2025 | $0.9718 | -0.89 |
Feb 3, 2025 | $1.08 | -0.99 |
Jan 2, 2025 | $1.26 | -1.16 |
Opus Genetics (IRD) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.14 | +4.59% |
2024 | -1.09 | -147.60% |
2023 | 2.29 | -176.33% |
2022 | -3.00 | +279.75% |
2021 | -0.79 | -24.04% |
2020 | -1.04 | — |
FAQs About Opus Genetics (IRD) P/E ratio
The latest P/E ratio of Opus Genetics (IRD) is -1.14, as of Oct 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Opus Genetics’s last 12-month average P/E ratio is -0.79, compared to its current P/E ratio of -1.14. This reflects a increase of 44.30%.
Opus Genetics’s current P/E ratio of -1.14 is higher than its last 12-month average P/E of -0.79. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Opus Genetics’s average P/E ratio over the last 3 years is 0.01. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Opus Genetics’s average P/E ratio over the last 5 years is -0.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.